Series A Financing Rounds

How to prepare a deal issues list from transaction documents for Series A Financing Rounds

Prepare a company-side Series A deal issues list with a copyable template, document comparisons, negotiation priorities, and a fictional worked example.

October 18, 2026  ·  10 min read
Book a Demo →

Prepare a company-side Series A deal issues list by comparing the agreed financing terms with the proposed charter, purchase agreement, investor rights documents, voting arrangements, disclosure schedules, and capitalization records. Record each material discrepancy or unresolved choice with precise sources, its company impact, a proposed position, and a decision owner. The deliverable should distinguish commercial concessions from drafting defects and factual gaps, identify decisions needed before signing or closing, and show whether agreed resolutions have been implemented consistently across the financing documents.

When to use this workflow

Use this workflow when company counsel receives integrated financing drafts, when investor revisions change the bargain, or before documents circulate for approval. It serves outside counsel, in-house teams, and executives responsible for financing economics and governance.

The scope is a U.S. private-company Series A financing by a Delaware corporation. Other incorporation jurisdictions, offering exemptions, and regulated businesses require separate analysis. This is a decision list, not a substitute for diligence, a capitalization model, or a closing checklist. Contract rights depend on the actual language, governing law, facts, and deal context.

What you need

Assemble a dated review set containing:

  • The agreed term sheet, amendments, and documented subsequent commercial decisions.
  • Current and proposed charters, bylaws, purchase agreement, investor rights agreement, voting agreement, and transfer-related agreements.
  • Disclosure schedules, side letters, proposed certificates, and closing conditions.
  • Stock ledger, option records, outstanding SAFEs and notes, conversion assumptions, and pre- and post-financing capitalization tables.
  • Existing investor rights and commercial, employment, and IP documents relevant to representations or consent questions.

Assign stable document IDs and identify version, execution status, entity, and missing attachments. Link amendments to their base documents. Establish negotiating authority: counsel should not assume authority to accept participation rights, pool dilution, or broader investor vetoes merely because counsel can resolve drafting errors.

Use the template

Use the Series A Financing Rounds — Deal issues list below. You can copy this table into your working document or spreadsheet.

ID / priority Sources / version Issue / type Company impact Company position Investor response Owner / decision gate Status / evidence

Use one row per decision, not per occurrence of repeated wording. Source fields should contain document IDs, sections, pages where useful, and model cell references for numerical questions. Cite both sides of a conflict.

Classify issues as commercial, drafting, factual, or approval-related; a row may have multiple classifications. Explain priority through consequence and urgency. State the preferred resolution and any authorized fallback. Preserve investor responses separately so silence is not mistaken for agreement.

The decision gate states when resolution is needed, such as before board circulation or initial closing. Distinguish proposed, agreed, implemented, and verified status. The final field should identify the implementing source and verifier, or the evidence still missing.

Step by step

1. Establish the comparison baseline

Number the reviewed versions and identify which term-sheet points changed through subsequent authorized decisions. Treat emails as evidence of instructions or negotiation history; still check the instruments intended to govern.

Map valuation, option-pool treatment, convertibles, liquidation economics, board composition, protective provisions, information rights, transfer rights, representations, and conditions to their operative documents. Include side letters: an apparently consistent principal agreement may not capture investor-specific rights.

Record: create rows for missing documents and disputed instructions. Identify who must confirm the bargain and whether the uncertainty prevents meaningful review of dependent provisions.

2. Reconcile financing economics and capitalization

Compare price, share numbers, pool treatment, and convertible-security assumptions across the purchase agreement, charter, and capitalization model. For SAFEs and notes, identify the applicable conversion language and inputs rather than treating a spreadsheet assumption as agreed wording.

Read preference multiple, participation, seniority, dividends, conversion, and deemed-liquidation provisions together. DGCL §151(a), (b), and (d) permits differing stock rights stated in the certificate or resolutions adopted under express charter authority, and separately addresses redemption and dissolution-distribution rights. It does not supply a particular negotiated preference.

Model alternative exit values using verified inputs where competing language changes distributions. Keep redemption separate from liquidation preference.

Record: cite conflicting provisions and model cells, explain the economic consequence, and assign finance and legal verification. Label results provisional if conversion or capitalization inputs remain unresolved.

3. Map governance and consent decisions

Compare board composition, protective provisions, voting commitments, and amendment mechanics. Separate statutory and charter approvals, board decisions, contractual operational consents, and amendments to the instruments containing those rights.

Read holder eligibility, denominator, threshold, exceptions, and sunsets together. Test the language against a later financing, debt incurrence, acquisition, and option-pool increase. Identify overlapping requirements without assuming that one approval satisfies another.

The 2023-filed investment agreement, Exhibit B §9.9, illustrates company and preferred-holder majority amendment consent with exceptions and additional protections. It is not a complete operational consent map.

Record: identify the constrained action, applicable instruments, requested flexibility, and authorized decision-maker. Link related rows where an amendment would require separate approval.

4. Convert diligence findings into document decisions

Read each proposed representation against evidence and disclosure schedules. Decide whether the finding requires factual confirmation, disclosure, narrower wording, third-party consent, or remediation. Do not convert every unanswered diligence request into a negotiation issue.

Review IP restrictions, exclusivity, assignment, financing-specific triggers, and termination rights independently of contract value. The historical RPX purchase agreement §2.12(b) addresses monetary obligations and distinct IP and business restrictions, subject to its qualifications. Its $10,000 threshold is not a universal diligence standard.

Record: cite the representation and underlying evidence; separate confirmed facts from uncertainty. Specify the proposed disclosure or drafting response. An absent amendment remains missing until obtained or expressly addressed, not “not applicable” by default.

5. Review continuing rights and closing dependencies

Check information rights, side letters, and conditions for unresolved scope or performance questions. Preserve recipient definitions, triggers, confidentiality protections, and exclusions. The 2023-filed agreement, Exhibit B §4.1, illustrates requested information rights qualified by Major Purchaser status and confidentiality and competitor provisions; it does not establish a general quarterly deadline.

For conditions, identify beneficiary, applicable closing, required evidence, and waiver authority. RPX §4 illustrates conditions at each closing and limits on waivers affecting nonconsenting investors. Read the actual financing rather than importing those mechanics.

Where Regulation D applies, flag uncertainty about the first sale. SEC Form D guidance, question 1, ties the 15-calendar-day period to the first investor’s irrevocable contractual commitment, not necessarily funding, with weekend and holiday adjustment. State notice requirements need separate review.

Record: retain unresolved scope, timing, and waiver decisions. Transfer routine delivery and filing tasks to the separate tracker with an owner; do not expand this list into a closing checklist.

6. Set the company position and negotiation sequence

Group related rows for management discussion: economics, control, operational obligations, then execution risks. Prioritize by consequence and urgency rather than document order. A missing assignment that threatens a condition may outrank a negotiable information-rights provision.

For each material issue, present the requested change, business reason, authorized fallback, and consequence of accepting the draft. Distinguish a legal or drafting defect requiring correction from a commercial concession requiring informed approval. “Nonstandard” is not a substitute for either analysis.

Record: enter the approved position, decision owner, and escalation point. Preserve conditional concessions and partial investor agreement rather than recording a broader settlement than the correspondence supports.

7. Verify implementation across the document set

Compare revised documents with agreed outcomes after each negotiation round. Check related definitions, schedules, side letters, and capitalization assumptions. A corrected preference provision may still leave inconsistent conversion language or an outdated purchase schedule.

Close a row only when implementation and required evidence have been checked. If a fact remains unresolved, keep that dependency visible even when the clause is acceptable. Preserve closed rows as a decision record rather than deleting their history.

Record: identify implementing version and section, verifier, and remaining dependencies. Carry open decisions explicitly into approval materials. If execution work moves elsewhere, record the destination and owner.

Worked example

Fictional scenario: Lumen Orchard Robotics, Inc., a Delaware corporation, is negotiating an $8 million Series A investment from Alder Quay Ventures. Its term sheet specifies a 1x nonparticipating preference, but the proposed charter awards the preference plus participation in remaining proceeds. Conversion inputs for an outstanding SAFE remain unconfirmed. The investor rights draft permits broad information access, and the diligence folder contains only an unsigned consultant IP assignment.

All parties, amounts, documents, and provisions below are fictional. Counsel assigns TS-01, CH-03, IRA-02, SPA-04, and IP-07 as document IDs.

ID / priority Sources / version Issue / type Company impact Company position Investor response Owner / decision gate Status / evidence
A-01 / high TS-01 §2; CH-03 Art. IV §2.1 Participation conflicts with term sheet; commercial Changes distributions; SAFE inputs unverified Restore nonparticipating preference; check conversion Counsel agrees in principle, subject to client approval CEO and finance lead / board circulation Open; revised charter and verified model required
A-02 / medium IRA-02 §3.2; TS-01 silent No competitor exclusion; commercial Sensitive plans could reach competitive holders Propose recipient limits and confidentiality protections Requests competitor definition General counsel / signing Open; recipient scope and fallback undecided
A-03 / high SPA-04 §§2.8, 4.7; IP-07 unsigned form Assignment evidence missing; factual and condition-related Representation and condition not confirmed Seek executed assignment; assess rights, disclosure, and condition No response Engineering lead and counsel / initial closing Open; no executed assignment located

A-01 supports a precise conformity request rather than an abstract demand for better economics. Counsel can identify participation from the charter text without inventing an exit allocation from unverified SAFE inputs.

A-02 is a new commercial decision: term-sheet silence does not establish an agreed competitor exclusion. Management must approve recipient limits and a fallback. A-03 requires evidence and legal analysis, not simply a narrower representation. An unsigned form does not prove execution or ownership, and disclosure alone does not establish satisfaction or waiver of the separate condition.

Common mistakes

  • Listing every redline. Consolidate repeated changes under the decision required; keep immaterial edits in the redline.
  • Ignoring side letters or existing rights. Include documents that could preserve conflicting rights or impose additional approvals.
  • Calling provisions “off-market” without support. Explain company-specific consequences. Filed agreements illustrate wording, not prevalence.
  • Using one generic consent row. Separate operational vetoes, amendment rights, corporate approvals, and condition waivers.
  • Resolving factual gaps through drafting alone. Verify evidence and condition treatment; acceptable language does not establish execution or satisfaction.

Final quality check

Before circulation, confirm:

  • Each material row cites the reviewed version and relevant provision.
  • Term-sheet deviations are distinguished from new commercial positions.
  • Economic analysis uses identified, verified inputs or expressly states uncertainty.
  • Governance analysis identifies eligible holders, thresholds, exceptions, and instruments.
  • Factual assertions have evidence; missing items remain visible.
  • Agreement, implementation, and verification have separate statuses.
  • Every open issue has an owner and decision gate or an explicit transfer destination.
  • Legal propositions and filed examples remain within their cited source support.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. In contract review, select the represented party in Word and provide deal-specific instructions. Findings quote clauses, rank severity, locate text, and identify missing language as not present. Lawyers can edit or insert suggestions as ordinary tracked changes in the signed-in Word user’s name, or dismiss findings with reasons. Tabular review supports work across documents; due diligence classification can organize supporting materials and prioritize human review. Counsel retains responsibility for decisions and verification. Book a demo to discuss this workflow.

Frequently asked questions

Should investors receive the internal issues list?

Create an external version when useful. Retain citations and requested changes, but remove internal fallback authority, sensitive deliberations, and management-only escalation notes. Review attachments and linked materials as well as the visible rows.

How detailed should each Series A issue be?

Include enough to decide it: source conflict, consequence, proposed resolution, and owner. Link longer capitalization analyses and evidence instead of reproducing them. Split a row when its components need different decisions or gates.

What if the term sheet omits a proposed right?

Label it a new commercial decision, not automatically a drafting error. Explain the effect on this company and obtain an authorized position. Detailed information access, side-letter benefits, and consent exceptions may require this treatment.

When can an issue move off the active list?

After implementation and verification, or an explicit transfer of remaining execution work. Preserve the resolution and destination. Do not remove unresolved facts merely because negotiations stopped or a certificate was drafted.

Sources

Filed agreements illustrate negotiated drafting, not universal requirements or market standards.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.

Run this workflow in DecoverAI

Clause-quoted findings, missing-language flags, and tracked changes in your name — with your team deciding every call. Plans from $299 per seat per month, SOC 2 Type II certified.

Book a demo
to learn more.
Book a Demo